vs
HA Sustainable Infrastructure Capital, Inc.（HASI）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是HA Sustainable Infrastructure Capital, Inc.的1.8倍（$207.3M vs $114.8M），HA Sustainable Infrastructure Capital, Inc.净利率更高（-46.8% vs -62.0%，领先15.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 13.3%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 4.2%）
HA可持续基础设施资本公司（HASI）是一家聚焦可持续基础设施领域的专业投资机构，业务覆盖可再生能源、能效提升、可持续地产及低碳公用事业板块，主要在北美市场运营，为合格绿色项目提供长期资本支持，为投资者创造稳定的经风险调整后回报。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
HASI vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.8M | $207.3M |
| 净利润 | $-53.8M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | -57.4% | -54.7% |
| 净利率 | -46.8% | -62.0% |
| 营收同比 | 13.3% | 25.9% |
| 净利润同比 | -176.7% | 3.5% |
| 每股收益（稀释后） | $-0.38 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $114.8M | $207.3M | ||
| Q3 25 | $103.1M | $159.9M | ||
| Q2 25 | $85.7M | $166.5M | ||
| Q1 25 | $96.9M | $139.3M | ||
| Q4 24 | $101.3M | $164.6M | ||
| Q3 24 | $82.0M | $139.5M | ||
| Q2 24 | $94.5M | $147.0M | ||
| Q1 24 | $105.8M | $108.8M |
| Q4 25 | $-53.8M | $-128.6M | ||
| Q3 25 | $83.3M | $-180.4M | ||
| Q2 25 | $98.4M | $-115.0M | ||
| Q1 25 | $56.6M | $-151.1M | ||
| Q4 24 | $70.1M | $-133.2M | ||
| Q3 24 | $-19.6M | $-133.5M | ||
| Q2 24 | $26.5M | $-131.6M | ||
| Q1 24 | $123.0M | $-170.7M |
| Q4 25 | -57.4% | -54.7% | ||
| Q3 25 | — | -106.9% | ||
| Q2 25 | — | -64.8% | ||
| Q1 25 | 84.7% | -102.6% | ||
| Q4 24 | 90.9% | -74.3% | ||
| Q3 24 | -32.1% | -94.6% | ||
| Q2 24 | 39.5% | -79.1% | ||
| Q1 24 | — | -151.9% |
| Q4 25 | -46.8% | -62.0% | ||
| Q3 25 | 80.8% | -112.8% | ||
| Q2 25 | 114.9% | -69.0% | ||
| Q1 25 | 58.4% | -108.5% | ||
| Q4 24 | 69.2% | -80.9% | ||
| Q3 24 | -23.9% | -95.7% | ||
| Q2 24 | 28.1% | -89.5% | ||
| Q1 24 | 116.3% | -156.8% |
| Q4 25 | $-0.38 | $-1.28 | ||
| Q3 25 | $0.61 | $-1.81 | ||
| Q2 25 | $0.74 | $-1.17 | ||
| Q1 25 | $0.44 | $-1.57 | ||
| Q4 24 | $0.58 | $-1.34 | ||
| Q3 24 | $-0.17 | $-1.40 | ||
| Q2 24 | $0.23 | $-1.52 | ||
| Q1 24 | $0.98 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.2M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $-80.0M |
| 总资产 | $8.2B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $110.2M | $421.0M | ||
| Q3 25 | $301.8M | $202.5M | ||
| Q2 25 | $86.5M | $176.3M | ||
| Q1 25 | $67.4M | $127.1M | ||
| Q4 24 | $129.8M | $174.0M | ||
| Q3 24 | $44.1M | $150.6M | ||
| Q2 24 | $145.7M | $480.7M | ||
| Q1 24 | $61.4M | $112.3M |
| Q4 25 | $2.7B | $-80.0M | ||
| Q3 25 | $2.7B | $9.2M | ||
| Q2 25 | $2.6B | $151.3M | ||
| Q1 25 | $2.5B | $144.2M | ||
| Q4 24 | $2.4B | $255.0M | ||
| Q3 24 | $2.3B | $346.8M | ||
| Q2 24 | $2.3B | $432.4M | ||
| Q1 24 | $2.3B | $140.3M |
| Q4 25 | $8.2B | $1.5B | ||
| Q3 25 | $8.2B | $1.2B | ||
| Q2 25 | $7.6B | $1.3B | ||
| Q1 25 | $7.5B | $1.3B | ||
| Q4 24 | $7.1B | $1.5B | ||
| Q3 24 | $6.7B | $1.5B | ||
| Q2 24 | $6.7B | $1.6B | ||
| Q1 24 | $6.7B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $167.3M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $167.3M | $-99.8M | ||
| Q3 25 | $-121.8M | $-91.4M | ||
| Q2 25 | $79.6M | $-108.3M | ||
| Q1 25 | $-37.1M | $-166.5M | ||
| Q4 24 | $5.9M | $-79.3M | ||
| Q3 24 | $21.9M | $-67.0M | ||
| Q2 24 | $-24.8M | $-77.0M | ||
| Q1 24 | $20.9M | $-190.7M |
| Q4 25 | — | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | — | $-79.0M | ||
| Q1 24 | — | $-193.9M |
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | — | -53.7% | ||
| Q1 24 | — | -178.2% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | -1.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | -0.66× | — | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.94× | — | ||
| Q1 24 | 0.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HASI
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
